Propensity-adjusted 8-year outcomes following bioprosthetic aortic valve replacement: The influence of novel anticalcification technologyCentral MessagePerspective

Objective: Aortic bioprostheses with RESILIA (Edwards Lifesciences) tissue technology have demonstrated robust outcomes through 7 years of follow-up. However, studies comparing RESILIA tissue valve outcomes to previous bioprosthetic valves are lacking. We sought to assess surgical aortic valve repla...

Descrición completa

Detalles Bibliográficos

Principais autores:	Tsuyoshi Kaneko, MD, Joseph E. Bavaria, MD, Vinod H. Thourani, MD, Douglas R. Johnston, MD
Formato:	Artigo
Idioma:	Inglês
Publicado:	Elsevier 2026-02-01
Series:	JTCVS Open
Assuntos:	aortic valve replacement aortic valve disease bioprosthetic valve RESILIA tissue long-term durability
Acceso en liña:	http://www.sciencedirect.com/science/article/pii/S2666273625004887
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!